Cargando…
Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
Chemotherapy resistance of tumor cells is a big challenge. Adaption to hypoxia is an essential cellular response that is controlled by the master oxygen-sensitive transcription factor HIF1 (hypoxia-inducible factor 1). The mechanism by which tumor cells acquire resistance to chemotherapy under hypox...
Autores principales: | Zhang, D, Shi, Z, Li, M, Mi, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611715/ https://www.ncbi.nlm.nih.gov/pubmed/24967963 http://dx.doi.org/10.1038/cddis.2014.240 |
Ejemplares similares
-
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
por: Rodriguez-Barrueco, Ruth, et al.
Publicado: (2017) -
MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
por: Oneyama, Chitose, et al.
Publicado: (2013) -
MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
por: Sun, Yan-ping, et al.
Publicado: (2016) -
miR-424(322)-5p targets
Ezh1 to inhibit the proliferation and differentiation of myoblasts
: miR-424(322)-5p regulates the proliferation and differentiation of myoblasts
por: Yue, Yongqi, et al.
Publicado: (2023) -
miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer
por: Wang, Xia, et al.
Publicado: (2016)